Atlas Trials

Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study

Clinical trial NCT02585934 · COMPLETED

Trial details

NCT number
NCT02585934
Sponsor
Axovant Sciences Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2015-10-01
Primary completion
2017-09-01
Enrollment
1315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.